Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP532759.RA9RrsZFRGL0v1JtHyh62HWMMm-OhAIoG5CTng3nvSO1U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP532759.RA9RrsZFRGL0v1JtHyh62HWMMm-OhAIoG5CTng3nvSO1U130_assertion type Assertion NP532759.RA9RrsZFRGL0v1JtHyh62HWMMm-OhAIoG5CTng3nvSO1U130_head.
- NP532759.RA9RrsZFRGL0v1JtHyh62HWMMm-OhAIoG5CTng3nvSO1U130_assertion wasGeneratedBy ECO_0000203 NP532759.RA9RrsZFRGL0v1JtHyh62HWMMm-OhAIoG5CTng3nvSO1U130_provenance.
- NP532759.RA9RrsZFRGL0v1JtHyh62HWMMm-OhAIoG5CTng3nvSO1U130_assertion wasDerivedFrom befree-2016 NP532759.RA9RrsZFRGL0v1JtHyh62HWMMm-OhAIoG5CTng3nvSO1U130_provenance.
- NP532759.RA9RrsZFRGL0v1JtHyh62HWMMm-OhAIoG5CTng3nvSO1U130_assertion SIO_000772 16435073 NP532759.RA9RrsZFRGL0v1JtHyh62HWMMm-OhAIoG5CTng3nvSO1U130_provenance.
- NP532759.RA9RrsZFRGL0v1JtHyh62HWMMm-OhAIoG5CTng3nvSO1U130_assertion evidence source_evidence_literature NP532759.RA9RrsZFRGL0v1JtHyh62HWMMm-OhAIoG5CTng3nvSO1U130_provenance.
- NP532759.RA9RrsZFRGL0v1JtHyh62HWMMm-OhAIoG5CTng3nvSO1U130_assertion description "[Further analysis of primary tumors indicated that the frequency of hypermethylation was high for ASC (82%) and PAX3 (86%) in all tumor types, and high for RIPK3 in small cell carcinoma (57%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP532759.RA9RrsZFRGL0v1JtHyh62HWMMm-OhAIoG5CTng3nvSO1U130_provenance.